PTC Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell PTCT and other ETFs, options, and stocks.

About PTCT

PTC Therapeutics, Inc. is a biopharmaceutical company, which focuses on the discovery, development, and commercialization of clinically differentiated medicines that provide benefits to patients with rare disorders. The company was founded by Allan Steven Jacobson and Stuart Walter Peltz on March 31, 1998 and is headquartered in Warren, NJ.

CEO

Matthew B. Klein

CEOMatthew B. Klein

Employees

991

Employees991

Headquarters

Warren, New Jersey

HeadquartersWarren, New Jersey

Founded

1998

Founded1998

Employees

991

Employees991

PTCT Key Statistics

Market cap

7.35B

Market cap7.35B

Price-Earnings ratio

-37.83

Price-Earnings ratio-37.83

Dividend yield

—

Dividend yield—

Average volume

3.04M

Average volume3.04M

High today

$89.85

High today$89.85

Low today

$85.60

Low today$85.60

Open price

$87.96

Open price$87.96

Volume

1.18M

Volume1.18M

52 Week high

$89.85

52 Week high$89.85

52 Week low

$43.18

52 Week low$43.18

Stock Snapshot

With a market cap of 7.35B, PTC Therapeutics(PTCT) trades at $88.57. The stock has a price-to-earnings ratio of -37.83.

During the trading session on 2026-07-08, PTC Therapeutics(PTCT) shares reached a daily high of $89.85 and a low of $85.60. At a current price of $88.57, the stock is +3.5% higher than the low and still -1.4% under the high.

Trading volume for PTC Therapeutics(PTCT) stock has reached 1.18M, versus its average volume of 3.04M.

The stock's 52-week range extends from a low of $43.18 to a high of $89.85.

PTCT News

Investing.com 1d

Ptc Therapeutics stock hits all-time high of 87.56 USD - Investing.com

...

TipRanks 2d

PTC Therapeutics price target raised to $85 from $82 at RBC Capital

RBC Capital raised the firm’s price target on PTC Therapeutics (PTCT) to $85 from $82 and keeps a Sector Perform rating on the shares as part of a broader resea...

Simply Wall St 2d

Does Triple Russell 2000 Defensive Index Inclusion Reframe PTC Therapeutics’ Risk Profile And Rare-Disease Story?

On 27 June 2026, PTC Therapeutics, Inc. was added to the Russell 2000 Value-Defensive, Growth-Defensive, and broader Defensive Indexes, marking its inclusion in...

Analyst ratings

73%

of 15 ratings

Buy

73.3%

Hold

20%

Sell

6.7%

More PTCT News

Simply Wall St 5d

Can PTC Therapeutics Be A Bargain On Its Russell Index Additions?

PTC Therapeutics (PTCT) is drawing fresh attention after being added to the Russell 2000 Value Defensive, Growth Defensive, and broader Defensive indices. This...

People also own

Based on the portfolios of people who own PTCT. This list is generated using Robinhood data, and it’s not a recommendation.

Taiwan Semiconductor Manu…

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.